Chloroquine makes comeback to combat malaria

October 3, 2012

Malaria-drug monitoring over the past 30 years has shown that malaria parasites develop resistance to medicine, and the first signs of resistance to the newest drugs have just been observed. At the same time, resistance monitoring at the University of Copenhagen shows that the previously efficacious drug chloroquine is once again beginning to work against malaria. In time that will ensure cheaper treatment for the world's poor.

Scientists and healthcare personnel the world over fear that the malaria parasite will develop to the current frontline treatment against malaria, Artemisinin-based Combination Therapies (ACTs). Therefore, it is especially good news that resistance monitoring at the University of Copenhagen shows that in several , malaria parasites are succumbing to the formerly used drug chloroquine. The results have just been published in the .

"70% of the malaria parasites we found in Senegal are reacting once again to chloroquine. This is a trend we have also seen in Tanzania and , and which other researchers have shown in Malawi. Our choice of drugs against malaria is limited and related, so when the malaria parasite once again reacts to a substance, it influences several treatment methods," explains Michael Alifrangis, associate professor at the Center for Medical Parasitology at the University of Copenhagen. He and Magatte Ndiaye, PhD student at Université Cheikh Anta Diop in Senegal, are keeping an eye on the malaria parasite's sensitivity to drugs by analyzing the parasites' .

Cheaper treatment for the poor in Africa

If healthcare personnel in can begin using chloroquine again, it will open up some promising perspectives. It will be possible to protect the currently used medicine and delay the reappearance of resistance, and it will also give a large group of patients access to cheaper treatment.

"Chloroquine costs only 25 US cents for a four-day cure, while the current and corresponding ACTs cost two dollars. Chloroquine was a fantastic malaria drug that lasted for 50 years. However, it was misused for malaria prevention and ordinary fever, and even mixed with cooking salt, so it can come as no surprise that the became resistant to the active ingredient," explains Professor Ib Bygbjerg, M.D. He also points out that reuse will require correct drug use and the training of healthcare personnel to make more accurate diagnoses.

Correct use of drugs paralyzes the development of resistance

According to Professor Ib Bygbjerg, three factors determine the extent to which a will work: 1) the size of the dose, 2) how sensitive the parasite is to the drug, and 3) the extent to which the patient has developed a natural immunity to malaria.

"In the near future, chloroquine and other malaria drugs not currently on the market will presumably be able to be used again, if we use them correctly. This means that the drug must be given in combination with other medicine and only to patients who have already developed a certain immunity to malaria and are therefore not at high risk. At the same time, we must reserve ACTs for the most exposed non-immune groups such as children. Chloroquine is one of the few drugs that can be given to pregnant women at the beginning of their pregnancy," points out Ib Bygbjerg, adding that the patient can be treated with a high dose for a short period, another benefit.

In order to maintain the positive development with , it is therefore also important that – with the exception of pregnant women – travellers to malaria areas refrain from taking the drug. Otherwise the parasites will quickly develop resistance once again.

Explore further: Aggressive drug therapy aids superbug evolution

Related Stories

New artemisinin-based treatment against malaria promising

November 8, 2011

For some time now, artemisinin, derived from a Chinese herb, has been the most powerful treatment available against malaria. To avoid the malaria parasite becoming resistant, the World Health Organisation (WHO) strongly recommends ...

Recommended for you

Monkeys in Asia harbor virus from humans, other species

November 19, 2015

When it comes to spreading viruses, bats are thought to be among the worst. Now a new study of nearly 900 nonhuman primates in Bangladesh and Cambodia shows that macaques harbor more diverse astroviruses, which can cause ...

One-step test for hepatitis C virus infection developed

November 14, 2015

UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the ...

Computer model reveals deadly route of Ebola outbreak

November 10, 2015

Using a novel statistical model, a research team led by Columbia University's Mailman School of Public Health mapped the spread of the 2014-2015 Ebola outbreak in Sierra Leone, providing the most detailed picture to date ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.